Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, and Holten Institute, Stockholm, Sweden (T.A.T.).
Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, and Rosenborg Fysioterapiklinikk, Trondheim, Norway (H.Ø.).
Ann Intern Med. 2023 Feb;176(2):154-165. doi: 10.7326/M22-2348. Epub 2023 Jan 24.
The benefits of exercise in patients with knee osteoarthritis are well documented, but the optimal exercise dose remains unknown.
To compare high-dose versus low-dose exercise therapy with regard to knee function, pain, and quality of life (QoL) in patients with long-term symptomatic knee osteoarthritis.
A Swedish and Norwegian multicenter randomized controlled superiority trial with multiple follow-ups up to 12 months after the intervention. (ClinicalTrials.gov: NCT02024126).
Primary health care facilities.
189 patients with diagnosed knee osteoarthritis and a history of pain and decreased knee function were assigned to high-dose therapy ( = 98; 11 exercises; 70 to 90 minutes) or low-dose therapy ( = 91; 5 exercises; 20 to 30 minutes).
Patient-tailored exercise programs according to the principles of medical exercise therapy. Global (aerobic), semiglobal (multisegmental), and local (joint-specific) exercises were performed 3 times a week for 12 weeks under supervision of a physiotherapist.
The Knee Injury and Osteoarthritis Outcome Score (KOOS) was measured biweekly during the 3-month intervention period and at 6 and 12 months after the intervention. The primary end point was the mean difference in KOOS scores between groups at the end of the intervention (3 months). Secondary outcomes included pain intensity and QoL. The proportion of patients with minimal clinically important changes in primary and secondary outcomes was compared between groups.
Both groups improved over time, but there were no benefits of high-dose therapy in most comparisons. One exception was the KOOS score for function in sports and recreation, where high-dose therapy was superior at the end of treatment and at 6-month follow-up. A small benefit in QoL at 6 and 12 months was also observed.
There was no control group that did not exercise.
The results do not support the superiority of high-dose exercise over low-dose exercise for most outcomes. However, small benefits with high-dose exercise were found for knee function in sports and recreation and for QoL.
Swedish Rheumatic Fund.
运动对膝骨关节炎患者的益处已有充分的文献记载,但最佳运动剂量仍不清楚。
比较高剂量与低剂量运动疗法对长期有症状的膝骨关节炎患者的膝关节功能、疼痛和生活质量(QoL)的影响。
瑞典和挪威的多中心随机对照优势试验,干预后最多进行 12 个月的多次随访。(ClinicalTrials.gov:NCT02024126)。
初级保健设施。
189 名被诊断为膝骨关节炎且有疼痛和膝关节功能下降病史的患者被分为高剂量治疗组(=98;11 项运动;70 至 90 分钟)或低剂量治疗组(=91;5 项运动;20 至 30 分钟)。
根据医学运动疗法的原则,为患者量身定制运动方案。全球(有氧运动)、半全球(多节段)和局部(关节特异性)运动每周进行 3 次,共 12 周,由物理治疗师监督。
在 3 个月的干预期间,每周测量 2 次 Knee Injury and Osteoarthritis Outcome Score(KOOS),在干预结束后 6 个月和 12 个月进行测量。主要终点是干预结束时(3 个月)两组之间 KOOS 评分的平均差异。次要结局包括疼痛强度和 QoL。比较两组患者在主要和次要结局中具有最小临床重要变化的比例。
两组患者的情况均随时间改善,但在大多数比较中,高剂量治疗并没有带来好处。一个例外是运动和娱乐功能的 KOOS 评分,高剂量治疗在治疗结束时和 6 个月随访时更优。在 6 个月和 12 个月时,QoL 也有小幅度的改善。
没有不运动的对照组。
结果不支持高剂量运动优于低剂量运动,大多数结局均如此。然而,高剂量运动对运动和娱乐功能的膝关节功能以及 QoL 有小的益处。
瑞典风湿基金。